- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04024111
Social Groups for Australian Children on the Autism Spectrum
The Development and Evaluation of a Social Skills Group Training for Australian Children on the Autism Spectrum
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Western Australia
-
Bentley, Western Australia, Australia, 6102
- Curtin University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Individuals aged 8 to 12
- Clinical consensus diagnosis of ASD as defined by DSM-5 and confirmed by the Autism Diagnostic Observation schedule-2
- IQ scores > 70 as measured by the Wechsler Abbreviated Scale of Intelligence - Second Edition (WASI-II)
Exclusion Criteria:
- Existing prior comorbid externalizing behaviours as assessed by the Childhood Behaviour Checklist (CBCL).
- Clinically assessed self-injurious behaviour • Low intrinsic motivation to participate in a social skills training group
- Insufficient English language skills
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: KONTAKT(c)
A social skills group training
|
KONTAKT is a manualized Social skills group training program designed for children and adolescents on the Autism Spectrum aimed at improving communication, social interaction skills, the severity of ASD symptoms, and the ability to empathise and adapt in a group setting.
The KONTAKT participants (4-8 participants) meet face to face weekly for 16 weeks for 75 minutes facilitated by two health professionals with experience of running groups for autistic children
|
Active Comparator: Art group
A social Art group
|
Art program, a manualized Art group delivered in a social format, has been designed for children on the Autism Spectrum delivered by health professionals with experience of running social groups for Autistic children.
The Art program's participants (4-8 participants) meet face to face weekly for 16 weeks for 75 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the Goal Attainment Scale (GAS)
Time Frame: Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
The GOAL Attainment Scale will be used to measure if the participants have achieved the goals they have set for the program.
Using the scale the children's primary outcome.
Using the scale the participants personally meaningful social goals will be specified, and a behavioural expectation that ranges from the worst to the best possible outcome will be listed for each goal.
This allows qualitative data to be quantified in relation to the success of the participant in achieving expectations of change.
The achievement of these goals will be scored via the GAS scoring system of "-2" showing the participant's current level of performance, "-1" less than expected, "0" the expected progress, and "+1" and "+2" indicative of progress above the expected level
|
Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
Change in Social Skills Assessment Questionnaire (SSAQ)
Time Frame: Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
Social Skills Assessment Questionnaire (SSAQ), is a 23-item parent proxy questionnaire measuring the change in a child's social skills abilities.
the measure is rated on a 3-point Likert scale from "worse than peers" to "Better than peers".
Higher total scores show better outcome.
This measure has been used with the ASD population before.
|
Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the Emotion Regulation Checklist (ERC)
Time Frame: Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
2.3.
The parents will fill this questionnaire (Parent form).
This is a 24-item measure assessing : negativity/lability and emotion regulation.
The questionnaire is designed to measure represents a different aspect of emotionality from a strengths perspective, i.e. emotional intelligence, resilience and coping and social and emotional competence.
Responses are rated on a 4-point Likert scale, ranging from "rarely" to "almost".
|
Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
Change in the Negative Incidents and Effects of Psychological Treatment (NEQ)
Time Frame: Post-test (week 20)
|
The parents (parent proxy) will fill this questionnaire.
The NEQ is a 32-item questionnaire requiring adolescents to quantify, on 5-point Likert scale with response options ranging from "Not at all" to "Extremely", any negative events experienced during the intervention period, asking participants to attribute their causality to either the program or external circumstances
|
Post-test (week 20)
|
Change in the Child Health Utility 9D (CHU9D)
Time Frame: Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
The children will fill this questionnaire.
This is a 9-dimension Health related quality of life scale (worried, sad, pain, tired, annoyed, school work, sleep, daily routines and activities), designed to estimate the adolescent's Quality adjusted life years (QALY), providing a standardized measure of disease burden.
The measure is rated on a 5-point scale with a "don't" sentence linked with no problems (e.g.
I don't feel sad today) and "very" with the participant experiencing a lot of problems (e.g.
I feel very sad).
Calculation of an universal score is supported by an adolescent specific scoring algorithm, with 1 representing 'full health' and 0 'death'.
|
Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
Change in Treatment Inventory of Costs in Patients (TIC-P)
Time Frame: Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
The parents will fill this questionnaire (Parent form). This will be measured via a tailored version of the Trimbos/iMTA questionnaire for patients with a psychiatric disorder (TiC-P), a well-established questionnaire examining health care usage as well as any work, education and productivity losses incurred by participants and their carers. The modified version of the TIC-P employed in this study comprise six sections enquiring about health care visits, support received - Page 4 of 6 [DRAFT] both at and outside of school, medications and supplements, work, and education and productivity losses incurred by both parents and children. |
Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
Treatment Satisfaction Scale
Time Frame: Post-test (week 20)
|
The children and parents both will fill this questionnaire.
This is a short 6-item parent and adolescents self-report instrument, measuring satisfaction with group attendance.
Each item is scored on a 4-point Likert scale with response options ranging from "Yes, very much" to "No" with an open comment section, encouraging participants to freely share their experiences with the intervention.
|
Post-test (week 20)
|
Change in the Social responsiveness scale - Second Edition (SRS-2)
Time Frame: Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
This measure will be used as the parent's primary outcome.The Social Responsiveness Scale - Second Edition (SRS-2) School-Age Form is a 65-item rating scale, designed to measure social deficits in individuals with ASD via parent proxy report has been used as the primary outcome in a previous study evaluating KONTAKT and has been used as the basis for the power calculation for the present RCT.
The SRS-2 (2014) enables calculation of a universal score and five treatment subscales: social awareness, social cognition, social communication, social motivation, and restricted interests and repetitive behaviour.
These subscales are designed to align closely with the DSM-5 criteria for ASD.
The scale takes approximately 15 to 20 minutes to complete with items scored on a 4-point Likert-type scale, ranging from "not true (0)" to "almost always true (3)".
The expected value for individuals with a primary diagnosis of ASD is approximately 100.
|
Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
International classification of functioning (ICF) - Autism coreset
Time Frame: Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
evaluates the impact of a disability and its context on an individual's functioning.
For the purpose of this study only item related to the KONTAKT© objectives (social communication and interaction) will be selected from the Autism Core set after the manual has been translated to English.
|
Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
Junior Temperament and characteristic Inventory (JTCI)
Time Frame: Baseline (week 0), Post-test (week 20) and follow up (week 36)
|
2.4.
This parent-report and child self-report is derived from the International classification of functioning's autism coreset that identifies the personality traits of young children aged 6-16 under 5. Responses are dichotomous (True or False).
|
Baseline (week 0), Post-test (week 20) and follow up (week 36)
|
Motivation to participate
Time Frame: Weekly through the intervention until post test time from week 1 to 20
|
is a weekly measure specifically designed for this study to evaluate the motivation to participate in the groups (both intervention and control) and will be assessed through a 2-item child and parent self-report and a parents proxy-report text, asking "On a scale of 1-5 (as demonstrated by emoji) how much did you like attending this week's group?" and "On a scale of 1-5 (as demonstrated by emoji) how interested are you in attending the next session?"
To check for reliability, the results from this measure will be attached to the participants' attendance in the groups.
|
Weekly through the intervention until post test time from week 1 to 20
|
Change in the LERID friendship questionnaire
Time Frame: Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
the LERID friendship questionnaire is a 46-item self-report measure of children's perceptions of the quality of their relationship with their best friend around 11 different aspects of friendship experience: commitment, security, satisfaction, intimacy, protection from victimization, help, affection received from the friend, trust of the friend, trust received from the friend, comfort, Validation and Authenticity of the friendship.
The measure is rated on a 5-point Likert scale from "Not true" (1) to "Really true" (5).
|
Baseline (week 0), Post-test (week 20) and follow up (week 36) and long follow up (74 weeks)
|
Change in the Social Interaction anxiety scale (SIAS)
Time Frame: Weekly through the intervention until post test time from week 1 to 20
|
Social Interaction Anxiety Scale (SIAS) is self-report used mainly with adults.
The measure has been used with adolescents participating in the KONTAKT program.
This study will only use the items which became significant in that study.
The measure is scored on a 5-point Likert scale from "Not at all (0)" to "Extremely (4)".
The higher scores on the scale indicate higher social interaction anxiety experienced.
|
Weekly through the intervention until post test time from week 1 to 20
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HRE2017-0245-34
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on KONTAKT(c)
-
Curtin UniversityKarolinska Institutet; Autism Association of Western AustraliaCompletedAutism Spectrum DisorderAustralia
-
Karolinska InstitutetThe Swedish Research Council; Region Stockholm; Stiftelsen Sunnerdahls Handikappfond and other collaboratorsCompletedDepression | Anxiety | Attention Deficit Hyperactivity Disorder (ADHD) | Autism Spectrum Disorder (ASD)Sweden
-
IlDong Pharmaceutical Co LtdCompleted
-
International Centre for Diarrhoeal Disease Research...University of California, DavisCompletedMalnourished Children
-
University of MiamiRecruitingHypoplastic Left Heart SyndromeUnited States
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedAdvanced CancerUnited Kingdom
-
Direction Centrale du Service de Santé des ArméesRecruitingEating Habit | Cold Exposure | HeatFrance
-
Kolon Life ScienceCompletedDegenerative ArthritisKorea, Republic of
-
U.S. Army Medical Research and Development CommandPPD; Idorsia Pharmaceuticals Ltd.; Berry Consultants; Cambridge Cognition Ltd; Ci...RecruitingPost Traumatic Stress DisorderUnited States